Immuron IMRN
NASDAQ IMRN
$1.15 -0.03 (-2.54%)
As of: Aug 21, 2026 · 11:06 AM EDT

Immuron (IMRN) Asset Utilization Ratio (2019 - 2024)

Immuron (IMRN) posted quarterly Asset Utilization Ratio of 2.71 for Q4 2024, down 98.84% year-over-year from 232.94 in Q1 2024, and down 98.84% quarter-over-quarter from 232.94 in Q4 2023.

Immuron (IMRN) Asset Utilization Ratio (2019 - 2024) Analysis & Trends

Immuron's Asset Utilization Ratio history runs 5 years deep, the most recent figure standing at 2.71 for Q4 2024.

  • In Q4 2024, Asset Utilization Ratio fell 98.84% year-over-year to 2.71; the TTM figure through Dec 2024 stood at 2.71 (down 98.84% YoY), while the FY2025 annual figure was 1.41, up 557.39% from the prior year.
  • Asset Utilization Ratio for Q4 2024 stood at 2.71, down from 232.94 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 232.94 in Q4 2023, with the low at 2.71 in Q4 2024.
  • The 4-year median for Asset Utilization Ratio is 160.97 (2021), against an average of 140.33.
  • The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio soared 131.49% in 2023, then sank 98.84% in 2024.
  • Immuron's Asset Utilization Ratio stood at 160.97 in 2021, then plunged by 37.49% to 100.62 in 2022, then jumped by 131.49% to 232.94 in 2023, then tumbled by 98.84% to 2.71 in 2024.
  • Business Quant data shows IMRN's Asset Utilization Ratio at 2.71 in Q4 2024, 232.94 in Q4 2023, and 204.39 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Vertex Pharmaceuticals 139.78 Bn 131.93 Bn 2.84 Bn 0.47
2 Regeneron Pharmaceuticals 86.58 Bn 78.59 Bn 3.93 Bn 0.38
3 Argenx Se 65.29 Bn 60.11 Bn 1.37 Bn -
4 Moderna 58.86 Bn 53.73 Bn 52.00 Mn 0.20
5 BeOne Medicines 42.12 Bn 37.02 Bn 1.53 Bn 0.69
6 Alnylam Pharmaceuticals 31.73 Bn 28.42 Bn 992.69 Mn 0.90
7 BioNTech SE 28.19 Bn 9.80 Bn 668.28 Mn 0.13
8 Insmed 27.53 Bn 26.37 Bn 358.27 Mn 0.54
9 Royalty Pharma 27.24 Bn 26.41 Bn - 0.13
10 Immuron 6.64 Mn 6.61 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 2.71
Dec 31, 2023 232.94
Jun 30, 2023 204.39
Dec 31, 2022 100.62
Dec 31, 2021 160.97
Dec 31, 2019 0.74